N/A N=10 Near Infrared Fluorescence Imaging for Bladder Cancer Detection
Bladder Cancer
Primary: Minimal Dwell Time
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=1,162 Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)
Non-valvular Atrial Fibrillation
Primary: Percentage of Days With a Correct Execution of the Apixaban Dosing Regimen — 91.64; 91.88 percentage of days — p=0.8117
Phase 3 N=225 A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
Leukemia
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 82; 84; 1; 3 Participants
N/A N=477 A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine
Migraine
Primary: Change in the Number of Migraine Days — -1.98; -1.53 Days
N/A N=306 Data Acquisition for Optimization of Coronary Artery Disease (CAD) Algorithm
Coronary Artery Disease
Primary: The Area Under the Receiver Operating Characteristic Curve of the CAD-score to Separate CAD From Non-CAD Patients. — 73.4 percentage of 100
N/A N=55 Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Chronic Low Back Pain · Hip Ostearthritis · Myofascial Pain Syndrome
Primary: Participants' Level of Low Back Pain-associated Disability as Assessed by Roland Morris Disability Questionnaire (RMDQ) — -1.29; -0.08 score on a scale — p=<0.05
N/A N=57 Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy Study
Mental Disorders · Mental Health Services
Primary: Change in Competitive Employment — 13.6 weeks — p=<.001
N/A N=74 A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Bone Metastasis
Primary: Patient's Change From Baseline of Pain Severity, as Measured by the Weekly Means of the Daily Average Pain Scores (APS) — 2.26 units on a scale
N/A N=48 Measuring the Implementation of the LiFE Program in Primary Care for Older Adults Aged 75 Years or Older
Chronic Disease
Primary: Feasibility of Recruitment — 48 Participants
N/A N=37 Learning Direct Laryngoscopy Using a McGrath Video Laryngoscope as Direct Versus Indirect Laryngoscope
Airway Management · Endotracheal Intubation · Medical Education
Primary: Intubation Success Rate — 14; 14 Participants
N/A N=30 Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study
Syncope, Vasovagal
Primary: Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination — 10; 0; 10 Participants
N/A N=53 Pivotal Response Group Treatment for Parents of Young Children With Autism
Autistic Disorder
Primary: Change From Baseline in Communication During Structured Lab Observation (SLO) at 12 Weeks — 45.7; 40.8; 64.5; 51.4 Utterances — p=0.42
N/A N=1,821 Prospective Evaluation of the Radiographic Efficacy of Enbrel
Rheumatoid Arthritis · Psoriasis Arthritis
Primary: Change From Baseline in Van Der Heijde Total Modified Total Sharp Score (mTSS) or Adapted mTSS at End of Phase 1 (Week 78): Efficacy Analysis Set (EAS) — 25.1; 14.7…
Phase 3 N=169 A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1
Hepatitis C Virus
Primary: Percentage of Participants With Sustained Virologic Response 12 (SVR12) in the Naive Cohort — 98.6 Percentage of Participants
N/A N=93 Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study
COPD Patients With Homogeneous Emphysema · Endoscopic Lung Volume Reduction With Endobronchial Valve
Primary: Percentage Change in Forced Expiratory Volume in 1 s (FEV1) (ITT Population) — 13.7; -3.2 percent change